To guard against hype, scientists studying oxytocin’s role in autism and its potential as a treatment need to embrace robust theories, rigorous delivery methods and reproducible research practices.
A new approach for delivering gene therapy to the brain reduces nerve damage in primates and could help make gene therapies for conditions related to autism safer.
Treatments for Rett syndrome that aim to boost levels of the protein MECP2 may not help everyone with the condition.
Mutations in the autism-linked gene ASH1L change how neurons grow and develop.
Intranasal oxytocin may spur new neuron growth and changes in social behavior after a few weeks.